Emergent BioSolutions
EBS
#8344
Rank
โ‚น29.26 B
Marketcap
โ‚น569.20
Share price
3.59%
Change (1 day)
-41.56%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2023 (TTM): -โ‚น991.84

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น323.11. In 2022 the company made an earnings per share (EPS) of -โ‚น420.80 a decrease over its 2021 EPS that were of โ‚น406.71.

EPS history for Emergent BioSolutions from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น991.84135.71%
2022-โ‚น420.80-203.46%
2021โ‚น406.71-25.09%
2020โ‚น542.90445.28%
2019โ‚น99.56-15.2%
2018โ‚น117.41-35.9%
2017โ‚น183.1669.57%
2016โ‚น108.02-27.67%
2015โ‚น149.3465.62%
2014โ‚น90.1711.63%
2013โ‚น80.7832.31%
2012โ‚น61.051.56%
2011โ‚น60.11-60.74%
2010โ‚น153.1059.8%
2009โ‚น95.8147.83%
2008โ‚น64.81-12.66%
2007โ‚น74.20-35.77%
2006โ‚น115.5359.76%
2005โ‚น72.3126.21%
2004โ‚น57.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น71.38-122.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น93.24-128.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น270.26-183.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น169.07-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น49.78-115.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.58 26.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น59.17-118.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel